Home
Conditions
Adenocarcinoma of the Rectum

Clinical trial condition

Adenocarcinoma of the Rectum

Explore clinical trials studying Adenocarcinoma of the Rectum. Study availability and eligibility vary by location and protocol.

33 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma of the Rectum trial results

Completed

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

NCT01037790

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum

NCT02641691

Conditions: Adenocarcinoma of the Rectum, Cancer of Rectum, Cancer of the Rectum, +15 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Midostaurin (PKC412) for Locally Advanced Rectal Cancer

NCT01282502

Conditions: Adenocarcinoma of the Rectum, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer

NCT01340755

Conditions: Adenocarcinoma of the Rectum, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer

NCT00307736

Conditions: Adenocarcinoma of the Rectum, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

NCT00100841

Conditions: Adenocarcinoma of the Rectum, Colonic Diseases, Colonic Neoplasms, +17 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

NCT01294826

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Swedish Medical Center Cancer Institute Seattle, Washington, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00032110

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

NCT00551421

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +18 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Adenocarcinoma of the Rectum

Adenocarcinoma of the Rectum trial results

Related conditions